<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02667756</url>
  </required_header>
  <id_info>
    <org_study_id>cro1532</org_study_id>
    <secondary_id>10/H0805/39</secondary_id>
    <nct_id>NCT02667756</nct_id>
  </id_info>
  <brief_title>Predicting Osteoarthritis Risk Following Knee Injury.</brief_title>
  <acronym>KICK</acronym>
  <official_title>Identification of Prognostic Biomarkers for Osteoarthritis Risk Following Knee Injury: the Knee Injury Cohort @ the Kennedy Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Imperial College Healthcare NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fortius Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>BUPA Cromwell Hospital, London, UK</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study seeks to identify and validate novel soluble biomarkers (within&#xD;
      blood, synovial fluid, urine) which contribute to the prognostic assessment of an individual&#xD;
      with an acute knee injury, a group of individuals in which ~50% will progress to symptomatic&#xD;
      radiographic knee osteoarthritis (OA).&#xD;
&#xD;
      150 individuals will be followed over 5 years with clinical assessment including validated&#xD;
      questionnaires, biological sampling and radiological imaging (X ray, magnetic resonance&#xD;
      imaging (MRI)).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in Knee Injury and Osteoarthritis Outcome Score (KOOS)-4 score at 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>Summary score for KOOS questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Kellgren Lawrence grade at 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>measured on X ray both knees</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Whole Organ MRI Score (WORMS) at 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>measured on MRI both knees</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in physical activity level (International Physical Activity Questionnaire, IPAQ) at 2 years</measure>
    <time_frame>2 years</time_frame>
    <description>validated activity questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in KOOS-4 score at 3 months</measure>
    <time_frame>3 months</time_frame>
    <description>Summary score for KOOS questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in KOOS-4 score at 5 years</measure>
    <time_frame>5 years</time_frame>
    <description>Summary score for KOOS questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Kellgren Lawrence grade at 5 years</measure>
    <time_frame>5 years</time_frame>
    <description>measured on X ray both knees</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in MRI WORMS score at 5 years</measure>
    <time_frame>5 years</time_frame>
    <description>Measured on MRI both knees</description>
  </secondary_outcome>
  <enrollment type="Actual">150</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Injury</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-interventional</intervention_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples include blood (plasma, serum, whole blood RNA, and where consent given, DNA), urine&#xD;
      and where undergoing a relevant clinical procedure to allow sampling, synovial fluid.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This is a non-intervention cohort study of subjects who have recently sustained a&#xD;
        structural knee injury. Individuals are identified from the practice of a collaborating&#xD;
        surgeon (AW) at a number of London sites, several of which are within private practice.&#xD;
        Because of the practice of the surgeon investigator, a large number will be sporting&#xD;
        professionals, or playing amateur sport at a high level.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinically significant acute knee injury within 8 weeks of recruitment&#xD;
&#xD;
          -  Aged 16-50&#xD;
&#xD;
          -  Knee effusion, evident clinically or by MRI&#xD;
&#xD;
          -  Evidence on MRI of structural injury (from list of relevant injuries)&#xD;
&#xD;
          -  Informed written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Knee injured more than 8 weeks prior to recruitment&#xD;
&#xD;
          -  Pre-existing advanced radiographic OA (Kellgren Lawrence (KL) grade 3-4) of same side&#xD;
             knee at baseline&#xD;
&#xD;
          -  Known history of inflammatory/septic arthritis of same side knee&#xD;
&#xD;
          -  Knee replacement - previous or planned within 2 years of study start&#xD;
&#xD;
          -  Active other (treated) inflammatory disease or infection&#xD;
&#xD;
          -  Positive pregnancy test&#xD;
&#xD;
          -  Not consenting, or contraindication to provide blood samples:&#xD;
&#xD;
               -  Bilateral mastectomy&#xD;
&#xD;
               -  Bilateral fistulae for renal dialysis&#xD;
&#xD;
          -  Unable to give informed written consent in English&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fiona Watt, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oxford</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kennedy Institute of Rheumatology, University of Oxford</name>
      <address>
        <city>Oxford</city>
        <state>Oxfordshire</state>
        <zip>OX3 7FY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://oacentre.kennedy.ox.ac.uk/</url>
    <description>Kennedy OA Centre homepage</description>
  </link>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>January 20, 2016</study_first_submitted>
  <study_first_submitted_qc>January 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2016</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>biomarker</keyword>
  <keyword>inflammation</keyword>
  <keyword>prognosis</keyword>
  <keyword>knee</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Knee Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

